Pharmaceuticals

Appeals Court Denies AstraZeneca in AWP Case, Hagens Berman Announces

Published in Health Insurance Week, October 11th, 2009

The First Circuit of the United States Court of Appeals yesterday upheld an earlier ruling of the trial court in a Massachusetts case against AstraZeneca (NYSE:AZN) that concluded the drug giant engaged in unfair and deceptive trade practices by inflating the price of prescription drug Zoladex, clearing the way for a national class-action lawsuit to move forward.

The 98-page ruling affirms a judgment of $12.9 million against the company for violating the Massachusetts Consumer Protection Act.

The ruling also clears the way for a national class-action lawsuit originally certified by U.S. District Court Judge Patti Saris on Sept. 29, 2008, which was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week

Source: Health Insurance Week (2009-10-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry